Mazooma Adds to Senior Management Team

Korry Dickout Joins as New Director of Marketing for Top igaming Fintech Company

Mazooma, the U.S. igaming industry’s preeminent payments company, has appointed Korry Dickout as Director of Marketing.

“So far, 2019 has been a record year thanks, in part, to the continuing expansion of online gambling and sports betting across the US,” said Mazooma CEO Justin Ferrabee. “Korry brings great skills and knowledge to help us solidify our market leadership position. I’m happy to welcome him to our senior management team.”

Korry has a successful track record in the payments sector which includes positions with Global Payments, TouchBistro and, most recently, Ceridian. He brings extensive technology industry experience too, having held senior marketing roles at large, multinational companies including IBM, Dell, Rogers Communications and Blackberry Limited.

At Mazooma, Korry will oversee all marketing and branding activity along with all stakeholder relations. He said, “I’m pleased to join Mazooma’s team and look forward to the challenges ahead as we continue to lead payments innovation in the fast-growing US igaming market.”

Notes to Editors:

Mazooma, Inc. is an innovative financial technology company that provides real-time, bank account level data intelligence and bank-verified payment processing for licensed online gaming and sports betting merchants in regulated U.S. markets. Mazooma’s patented online banking verification technology has been used by millions of consumers, processed over $35 Billion in volume, and can be found on the checkout of every regulated igaming operator in the country.

Total
0
Shares
Leave a Reply
Related Posts
Read More

Covanos Named Platinum Winner at Cleveland Clinic’s 2019 Medical Innovation Summit AMP’D Arena Competition

Covanos, Inc., an Atlanta-based private medical technology company, was named the Platinum Winner of the AMP'D Arena Pitch Competition at the 2019 Medical Innovation Summit, organized by Cleveland Clinic and co-sponsored by the Wallace H. Coulter Foundation. The Company's first product-in-development, C-HEART is a PC-based software product that uses proprietary advances in computational fluid dynamics to rapidly and non-invasively identify whether blockages in coronary arteries require a medical intervention, such as surgery or stent.